BNIP3L and hepatocellular carcinoma: Since we confirmed the negative relationship between BNIP3/BNIP3L levels and sorafenib sensitivity in the last section, we subsequently detected whether combining sorafenib with MenSCs would resensitize HCC-SR cells to sorafenib.